When Lisa Volenec was diagnosed with Parkinson’s disease in 2014, she struggled to accept a future shaped by a progressive neurological disorder with no cure.
The global collaborative research initiative will initially target Alzheimer’s, Parkinson’s, Huntington’s disease, ALS, and Lewy body dementia.
The Parkinson’s Precision Medicine Initiative (PPMI) is our landmark study. It gathers information over time to learn more about how brain disease starts and changes and how to stop it. Now it needs you.
We use cookie to improve your experience on our site. By using our site you consent cookies, but you can opt-out if you wish. Read More